COPD Medication Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: C9C69F2A7956EN
Market Monitor Global

Abstracts

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. It's typically caused by long-term exposure to irritating gases or particulate matter, most often from cigarette smoke.

This report contains market size and forecasts of COPD Medication in Global, including the following market information:

Global COPD Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global COPD Medication market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Short-Acting Bronchodilator Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of COPD Medication include Roche, Novartis, GSK, Teva, AstraZeneca, Boehringer Ingelheim and Nephron Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COPD Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COPD Medication Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global COPD Medication Market Segment Percentages, by Type, 2021 (%)

• Short-Acting Bronchodilator
• Corticosteroids
• Methylxanthines
• Long-Acting Bronchodilators
• Combination Drugs

Global COPD Medication Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global COPD Medication Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Pharmacy
• Online Pharmacy

Global COPD Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global COPD Medication Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies COPD Medication revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies COPD Medication revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Novartis
• GSK
• Teva
• AstraZeneca
• Boehringer Ingelheim
• Nephron Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 COPD Medication Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global COPD Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COPD MEDICATION OVERALL MARKET SIZE

2.1 Global COPD Medication Market Size: 2021 VS 2028
2.2 Global COPD Medication Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top COPD Medication Players in Global Market
3.2 Top Global COPD Medication Companies Ranked by Revenue
3.3 Global COPD Medication Revenue by Companies
3.4 Top 3 and Top 5 COPD Medication Companies in Global Market, by Revenue in 2021
3.5 Global Companies COPD Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 COPD Medication Players in Global Market
  3.6.1 List of Global Tier 1 COPD Medication Companies
  3.6.2 List of Global Tier 2 and Tier 3 COPD Medication Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global COPD Medication Market Size Markets, 2021 & 2028
  4.1.2 Short-Acting Bronchodilator
  4.1.3 Corticosteroids
  4.1.4 Methylxanthines
  4.1.5 Long-Acting Bronchodilators
  4.1.6 Combination Drugs
4.2 By Type - Global COPD Medication Revenue & Forecasts
  4.2.1 By Type - Global COPD Medication Revenue, 2017-2022
  4.2.2 By Type - Global COPD Medication Revenue, 2023-2028
  4.2.3 By Type - Global COPD Medication Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global COPD Medication Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Pharmacy
  5.1.5 Online Pharmacy
5.2 By Application - Global COPD Medication Revenue & Forecasts
  5.2.1 By Application - Global COPD Medication Revenue, 2017-2022
  5.2.2 By Application - Global COPD Medication Revenue, 2023-2028
  5.2.3 By Application - Global COPD Medication Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global COPD Medication Market Size, 2021 & 2028
6.2 By Region - Global COPD Medication Revenue & Forecasts
  6.2.1 By Region - Global COPD Medication Revenue, 2017-2022
  6.2.2 By Region - Global COPD Medication Revenue, 2023-2028
  6.2.3 By Region - Global COPD Medication Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America COPD Medication Revenue, 2017-2028
  6.3.2 US COPD Medication Market Size, 2017-2028
  6.3.3 Canada COPD Medication Market Size, 2017-2028
  6.3.4 Mexico COPD Medication Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe COPD Medication Revenue, 2017-2028
  6.4.2 Germany COPD Medication Market Size, 2017-2028
  6.4.3 France COPD Medication Market Size, 2017-2028
  6.4.4 U.K. COPD Medication Market Size, 2017-2028
  6.4.5 Italy COPD Medication Market Size, 2017-2028
  6.4.6 Russia COPD Medication Market Size, 2017-2028
  6.4.7 Nordic Countries COPD Medication Market Size, 2017-2028
  6.4.8 Benelux COPD Medication Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia COPD Medication Revenue, 2017-2028
  6.5.2 China COPD Medication Market Size, 2017-2028
  6.5.3 Japan COPD Medication Market Size, 2017-2028
  6.5.4 South Korea COPD Medication Market Size, 2017-2028
  6.5.5 Southeast Asia COPD Medication Market Size, 2017-2028
  6.5.6 India COPD Medication Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America COPD Medication Revenue, 2017-2028
  6.6.2 Brazil COPD Medication Market Size, 2017-2028
  6.6.3 Argentina COPD Medication Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa COPD Medication Revenue, 2017-2028
  6.7.2 Turkey COPD Medication Market Size, 2017-2028
  6.7.3 Israel COPD Medication Market Size, 2017-2028
  6.7.4 Saudi Arabia COPD Medication Market Size, 2017-2028
  6.7.5 UAE COPD Medication Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche COPD Medication Major Product Offerings
  7.1.4 Roche COPD Medication Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis COPD Medication Major Product Offerings
  7.2.4 Novartis COPD Medication Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 GSK
  7.3.1 GSK Corporate Summary
  7.3.2 GSK Business Overview
  7.3.3 GSK COPD Medication Major Product Offerings
  7.3.4 GSK COPD Medication Revenue in Global Market (2017-2022)
  7.3.5 GSK Key News
7.4 Teva
  7.4.1 Teva Corporate Summary
  7.4.2 Teva Business Overview
  7.4.3 Teva COPD Medication Major Product Offerings
  7.4.4 Teva COPD Medication Revenue in Global Market (2017-2022)
  7.4.5 Teva Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca COPD Medication Major Product Offerings
  7.5.4 AstraZeneca COPD Medication Revenue in Global Market (2017-2022)
  7.5.5 AstraZeneca Key News
7.6 Boehringer Ingelheim
  7.6.1 Boehringer Ingelheim Corporate Summary
  7.6.2 Boehringer Ingelheim Business Overview
  7.6.3 Boehringer Ingelheim COPD Medication Major Product Offerings
  7.6.4 Boehringer Ingelheim COPD Medication Revenue in Global Market (2017-2022)
  7.6.5 Boehringer Ingelheim Key News
7.7 Nephron Pharmaceuticals
  7.7.1 Nephron Pharmaceuticals Corporate Summary
  7.7.2 Nephron Pharmaceuticals Business Overview
  7.7.3 Nephron Pharmaceuticals COPD Medication Major Product Offerings
  7.7.4 Nephron Pharmaceuticals COPD Medication Revenue in Global Market (2017-2022)
  7.7.5 Nephron Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. COPD Medication Market Opportunities & Trends in Global Market
Table 2. COPD Medication Market Drivers in Global Market
Table 3. COPD Medication Market Restraints in Global Market
Table 4. Key Players of COPD Medication in Global Market
Table 5. Top COPD Medication Players in Global Market, Ranking by Revenue (2021)
Table 6. Global COPD Medication Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global COPD Medication Revenue Share by Companies, 2017-2022
Table 8. Global Companies COPD Medication Product Type
Table 9. List of Global Tier 1 COPD Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 COPD Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global COPD Medication Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - COPD Medication Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - COPD Medication Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global COPD Medication Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - COPD Medication Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - COPD Medication Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global COPD Medication Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global COPD Medication Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global COPD Medication Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America COPD Medication Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America COPD Medication Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe COPD Medication Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe COPD Medication Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia COPD Medication Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia COPD Medication Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America COPD Medication Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America COPD Medication Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa COPD Medication Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa COPD Medication Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche COPD Medication Product Offerings
Table 32. Roche COPD Medication Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis COPD Medication Product Offerings
Table 35. Novartis COPD Medication Revenue (US$, Mn), (2017-2022)
Table 36. GSK Corporate Summary
Table 37. GSK COPD Medication Product Offerings
Table 38. GSK COPD Medication Revenue (US$, Mn), (2017-2022)
Table 39. Teva Corporate Summary
Table 40. Teva COPD Medication Product Offerings
Table 41. Teva COPD Medication Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca COPD Medication Product Offerings
Table 44. AstraZeneca COPD Medication Revenue (US$, Mn), (2017-2022)
Table 45. Boehringer Ingelheim Corporate Summary
Table 46. Boehringer Ingelheim COPD Medication Product Offerings
Table 47. Boehringer Ingelheim COPD Medication Revenue (US$, Mn), (2017-2022)
Table 48. Nephron Pharmaceuticals Corporate Summary
Table 49. Nephron Pharmaceuticals COPD Medication Product Offerings
Table 50. Nephron Pharmaceuticals COPD Medication Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. COPD Medication Segment by Type in 2021
Figure 2. COPD Medication Segment by Application in 2021
Figure 3. Global COPD Medication Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global COPD Medication Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global COPD Medication Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by COPD Medication Revenue in 2021
Figure 8. By Type - Global COPD Medication Revenue Market Share, 2017-2028
Figure 9. By Application - Global COPD Medication Revenue Market Share, 2017-2028
Figure 10. By Region - Global COPD Medication Revenue Market Share, 2017-2028
Figure 11. By Country - North America COPD Medication Revenue Market Share, 2017-2028
Figure 12. US COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 13. Canada COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe COPD Medication Revenue Market Share, 2017-2028
Figure 16. Germany COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 17. France COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 19. Italy COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 20. Russia COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia COPD Medication Revenue Market Share, 2017-2028
Figure 24. China COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 25. Japan COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 28. India COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America COPD Medication Revenue Market Share, 2017-2028
Figure 30. Brazil COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa COPD Medication Revenue Market Share, 2017-2028
Figure 33. Turkey COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 34. Israel COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 36. UAE COPD Medication Revenue, (US$, Mn), 2017-2028
Figure 37. Roche COPD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis COPD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GSK COPD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva COPD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca COPD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boehringer Ingelheim COPD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Nephron Pharmaceuticals COPD Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)